Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid.
Southeast Asian J Trop Med Public Health
; 2004 Mar; 35(1): 172-4
Article
de En
| IMSEAR
| ID: sea-33444
To study the efficacy of the combination of albendazole and prednisolone for the treatment of eosinophilic meningitis, we conducted a pilot study among Thai patients with eosinophilic meningitis. Patients were given a 2-week course of prednisolone, 60 mg/day and albendazole, 15 mg/kg/ day. The primary observation parameter was the number of patients who still had headache after the 2-week course of treatment. Twenty-six patients were enrolled in the study. There were 3 (11.5%) patients who still had headache after the 2-week course of treatment and the median length of time until complete disappearance of headache was 4 days. Serious side effects were not detected. Treatment for 2 weeks with the combination regimen of albendazole and prednisolone is safe and effective for the treatment of eosinophilic meningitis.
Texte intégral:
1
Indice:
IMSEAR
Sujet Principal:
Thaïlande
/
Indice de gravité de la maladie
/
Femelle
/
Humains
/
Mâle
/
Calendrier d'administration des médicaments
/
Prednisolone
/
Albendazole
/
Administration par voie orale
/
Études prospectives
Type d'étude:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Pays comme sujet:
Asia
langue:
En
Texte intégral:
Southeast Asian J Trop Med Public Health
Année:
2004
Type:
Article